Join us for an essential discussion on the next steps in preventing cargo crime with TAPA Incident Information Service (IIS) as the world move towards the recovery phase of COVID-19. The IIS is designed as a database to provide ‘flash’ incident alerts and trend analysis reports for cargo security globally. As logistic service providers adapt to new routes, temporary storage solutions and changes in transportation modes, supply chains now face new risks arising from increased transportation time, custom delays and technological challenges. In this webinar, we will share global cargo security landscape, latest insights, case studies of recent cargo crime and best IIS practices to address the changing realities with COVID-19.
What you will learn:
- Latest trends and case studies on recent crime
- Key statistical insights in 2020 on cargo crime ‘hotspots’, modus operandi and highly targeted goods
- How to prevent cargo crime with TAPA Incident Information Service (IIS)
- Best practices on collaborative data-sharing with IIS to address the changing realities with COVID-19
- New risks arising in the Pharmaceutical supply chain and strategies to address these challenges for a resilient supply chain
- Post-COVID outlook on cargo crime
0:08:29 – Top Asia Pacific countries for cargo theft include India, China, Indonesia and Vietnam. Theft from facility and vehicles are increasingly the most common modality used by criminals.
0:09:46 – IIS serves as a centralized portal where members can find out what companies have done during their recovery process.
0:27:45 – Moving into the COVID-19 reopening phase, all the parcels will flood the Customs departments and criminal syndicates will also take this opportunity to take advantage to swamp the world with counterfeits.
0:33:40 – Data intelligence and reporting is not a one-way street. We need everyone to contribute data so that information can be analyzed and shared with LEAs.
0:43:01 – Cargo routes should be reviewed at least twice a year with risk assessment completed for LSPs. Security requirements must be met for certification.
About the Speakers
IIS Working Committee at Transported Asset Protection Association, TAPA
Selvaraj is the Head of Infrastructure, Safety, and Environmental Sustainability & Engineering (ISEE) and Security at Boehringer Ingelheim Singapore Pte. Ltd. in Asia Pacific. With a combination of his expertise in both Safety and Security, he is able to advise and lead organisations towards recovery and maintain operational capabilities at the same time in any situations.
Regional Director for Asia Pacific of Pharmaceutical Security Institute
Ramesh has a distinguished career with the Health Sciences Authority (HSA), Singapore. He was the Head of the Enforcement Operations Unit overseeing field enforcement activities, surveillance, seizure management and coordinated efforts with other law enforcement agencies. His accomplishments included several successfully prosecuted landmark cases involving rouge medical practitioners and counterfeit medical devices.
Chairman for Asia Pacific at Transported Asset Protection Association, TAPA
Tony is the Director of Logistics Purchasing and Centre of Excellence for Lear Corporation Asia Pacific, the Leading Tier 1 global automotive manufacturer ranked #148 on the Fortune 500, for its Seating (JIT) & E-Systems Divisions across Asia Pacific and global distribution, sequencing & warehousing.
Tony also sits on the Emeritus Council of Advisors for Supply Chain Asia.
About TAPA Incident Information Service (IIS)
TAPA’s Incident Information Service was designed to improve the availability and flow of information on crimes against logistics supply chains within industry and between industry and Law Enforcement Agencies. For more information, visit TAPA Incident Information Service (IIS)
About Pharmaceutical Security Institute
Counterfeit medicinal products are a threat to the health and safety of patients around the world. They range from drugs with no active ingredients to those with dangerous impurities. They can be copies of branded drugs, generic drugs or over-the-counter drugs.
In 2002, the Security Directors from fourteen major pharmaceutical companies established the Institute in Washington, D.C. Working with its members, PSI developed improved systems to identify the extent of the problem and to assist in coordinating international inquiries.
Today, PSI membership includes thirty-seven pharmaceutical manufacturers from many nations. The Institute established representational offices with staff in Miami, Florida; Singapore; and Stockholm, Sweden.